Track insider trading activity from Boston Scientific (BSX) executives and directors. Boston Scientific is a global medical technology leader, developing, manufacturing, and marketing medical devices across various interventional specialties. The company's insiders, including Chairman and CEO Michael F. Mahoney, have generally shown a pattern of selling shares over the past year and recent quarters, with significantly more shares sold than purchased. This activity is sometimes attributed to portfolio diversification and broader industry trends rather than necessarily indicating a negative outlook for the company.
Join Stockcircle to see more insider trades and be the first to know about new executive transactions.
Sign UpTo improve your user experience we use cookies. Privacy Policy
Necessary for the website to function.
Help us understand how you use our site.
Used to show relevant ads.